PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings.
Leathers JS, Balderramo D, Prieto J, Diehl F, Gonzalez-Ballerga E, Ferreiro MR, Carrera E, Barreyro F, Diaz-Ferrer J, Singh D, Mattos AZ, Carrilho F, Debes JD.
Hepat Mon. 2018 Oct;18(10). pii: e82345. doi: 10.5812/hepatmon.82345. Epub 2018 Oct 21. No abstract available.
PMID: 30467514
Sorafenib for Treatment of Hepatocellular Carcinoma: A Survival Analysis From the South American Liver Research Network.
S Leathers J, Balderramo D, Prieto J, Diehl F, Gonzalez-Ballerga E, Ferreiro MR, Carrera E, Barreyro F, Diaz-Ferrer J, Singh D, Mattos AZ, Carrilho F, Debes JD.
J Clin Gastroenterol. 2018 Jun 26. doi: 10.1097/MCG.0000000000001085. [Epub ahead of print]
PMID: 29952857
Early hepatocellular carcinoma in South America: What is to blame?
Debes JD.
Liver Int. 2018 May;38(5):957-958. doi: 10.1111/liv.13717. No abstract available.
PMID: 29702743
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy.
Debes JD, Chan AJ, Balderramo D, Kikuchi L, Gonzalez Ballerga E, Prieto JE, Tapias M, Idrovo V, Davalos MB, Cairo F, Barreyro FJ, Paredes S, Hernandez N, Avendaño K, Diaz Ferrer J, Yang JD, Carrera E, Garcia JA, Mattos AZ, Hirsch BS, Gonçalves PT, Carrilho FJ, Roberts LR.
Liver Int. 2018 Jan;38(1):136-143. doi: 10.1111/liv.13502. Epub 2017 Jul 18.
PMID: 28640517
Early Age Hepatocellular Carcinoma Associated With Hepatitis B Infection in South America.
Chan AJ, Balderramo D, Kikuchi L, Ballerga EG, Prieto JE, Tapias M, Idrovo V, Davalos MB, Cairo F, Barreyro FJ, Paredes S, Hernandez N, Avendaño K, Ferrer JD, Yang JD, Carrera E, Mattos AZ, Hirsch BS, Gonçalves PT, Carrilho FJ, Roberts LR, Debes JD.
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1631-1632. doi: 10.1016/j.cgh.2017.05.015. Epub 2017 May 19. No abstract available.
PMID: 28532694